Prime Medicine (PRME) Asset Utilization Ratio (2024 - 2026)

Prime Medicine posted quarterly Asset Utilization Ratio of 0.01 for Q1 2026, up 2.95% year-on-year from 0.01 in Q1 2025, and down 0.58% on a QoQ basis from 0.01 in Q4 2025.

Prime Medicine (PRME) has 3 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 2.95% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.01 (up 2.95% YoY), and the FY2025 full-year result was 0.01, up 19.17% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.01, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q3 2025 and bottomed at 0.0 in Q2 2024.
  • The 3-year median for Asset Utilization Ratio is 0.01 (2025), against an average of 0.01.
  • The widest annual swing landed in 2025, when Asset Utilization Ratio soared 689.54%; it then climbed 2.95% in 2026.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.01 in 2024, then surged by 34.49% to 0.01 in 2025, then dropped by 0.58% to 0.01 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.47
7 Evaxion A 62.56 Bn 62.54 Bn - 0.29
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.85
10 Prime Medicine 601.24 Mn 601.24 Mn - 0.01

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.02
Jun 30, 2025 0.02
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00